April 2020 : State of Pharmacy Compounding - Vol.17 No. 4 - Page #54

While the rate of recalls from outsourced compounders has leveled off over the past 2 years, these disruptions continue to pose a significant operational threat. It is clear that recalls are not only unlikely to completely disappear, spikes in recall frequency are likely to occur. Therefore, pharmacy must be able to respond quickly and effectively when recalls arise. Recognizing this urgency, a growing number of facilities have adopted recall systems.

Reflecting pharmacy’s commitment to establishing contingency plans, 8 out of every 10 facilities have implemented a recall system for their compounded products.

Recalls of in-house compounding were at an all-time low this year; just 5% of facilities experienced a recall from in-house CSP production. Recalls of outsourced products impacted 21% of facilities.

The ability to identify all patients who receive a recalled product is an excellent measure of the effectiveness of a given recall system. For in-house recalls, 8 out of 10 facilities experiencing recalls were able to identify all affected patients. The success rate drops for recalls of outsourced products; just 67% of facilities experiencing a recall of an outsourced product successfully identified all affected patients.

Pharmacy directors are exceedingly confident in their systems for identifying and isolating in-house compounded medications under recall. It is notable that recall systems for outsourced products also receive high marks even though they are not always effective at identifying each affected patient.


Like what you've read? Please log in or create a free account to enjoy more of what has to offer.

Current Issue